An	O
S116R	B:C1519254
Phosphorylation	I:C1519254
Site	I:C1519254
Mutation	B:C0026882
in	O
Human	B:C0086418
Fibroblast	B:C0079349
Growth	I:C0079349
Factor	I:C0079349
-	I:C0079349
1	I:C0079349
Differentially	O
Affects	O
Mitogenic	B:C1752930
and	O
Glucose	B:C0860801
-	I:C0860801
Lowering	I:C0860801
Activities	I:C0860801
.	O

Fibroblast	B:C0079349
growth	I:C0079349
factor	I:C0079349
-	I:C0079349
1	I:C0079349
(	O
Fibroblast	B:C0079349
growth	I:C0079349
factor	I:C0079349
-	I:C0079349
1	I:C0079349
)	O
,	O
a	O
potent	O
human	B:C0086418
mitogen	B:C0018284
and	O
insulin	B:C0021641
sensitizer	O
,	O
signals	B:C0037080
through	O
both	O
tyrosine	B:C0206364
kinase	I:C0206364
receptor	I:C0206364
-	O
mediated	O
autocrine	B:C0525010
/	O
paracrine	O
pathways	O
as	O
well	O
as	O
a	O
nuclear	B:C0521447
intracrine	B:C1154545
pathway	I:C1154545
.	O

Phosphorylation	B:C0031715
of	O
Fibroblast	B:C0079349
growth	I:C0079349
factor	I:C0079349
-	I:C0079349
1	I:C0079349
at	O
serine	B:C0036720
116	I:C0036720
(	O
serine	B:C0036720
116	I:C0036720
)	O
has	O
been	O
proposed	O
to	O
regulate	B:C3158094
intracrine	B:C1154545
signaling	I:C1154545
.	O

Position	O
serine	B:C0036720
116	I:C0036720
is	O
located	O
within	O
a	O
∼	O
17	O
amino	B:C1707271
acid	I:C1707271
C-	I:C1707271
terminal	I:C1707271
loop	I:C1707271
that	O
contains	O
a	O
rich	O
set	O
of	O
functional	B:C0574031
determinants	I:C0574031
including	O
heparin	B:C0019134
∖	O
heparan	B:C0019143
sulfate	I:C0019143
affinity	O
,	O
thiol	B:C0038734
reactivity	O
,	O
nuclear	B:C0525021
localization	I:C0525021
,	O
pharmacokinetics	O
,	O
functional	O
half	O
-	O
life	O
,	O
nuclear	B:C0521447
ligand	B:C0023688
affinity	O
,	O
stability	O
,	O
and	O
structural	B:C0596957
dynamics	I:C0596957
.	O

Mutational	B:C0026882
targeting	O
of	O
specific	O
functionality	O
in	O
this	O
region	O
without	O
perturbing	O
other	O
functional	B:C0574031
determinants	I:C0574031
is	O
a	O
design	O
challenge	O
.	O

S116R	B:C0036720
is	O
a	O
non-phosphorylatable	B:C0243095
variant	O
present	O
in	O
bovine	B:C3667982
Fibroblast	B:C0079349
growth	I:C0079349
factor	I:C0079349
-	I:C0079349
1	I:C0079349
and	O
other	O
members	O
of	O
the	O
human	B:C0086418
FGF	B:C0016026
family	I:C0016026
.	O

We	O
show	O
that	O
the	O
S116R	B:C0026882
mutation	I:C0026882
in	O
human	B:C0086418
Fibroblast	B:C0079349
growth	I:C0079349
factor	I:C0079349
-	I:C0079349
1	I:C0079349
is	O
accommodated	O
with	O
no	O
perturbation	O
of	O
biophysical	O
or	O
structural	B:C0026383
properties	O
,	O
and	O
is	O
therefore	O
an	O
attractive	O
mutation	B:C0026882
with	O
which	O
to	O
elucidate	O
the	O
functional	O
role	O
of	O
phosphorylation	B:C0031715
.	O

Characterization	O
of	O
S116	B:C0036720
R	I:C0036720
shows	O
reduction	O
in	O
NIH	B:C1257739
3T3	I:C1257739
fibroblast	B:C0016030
mitogenic	B:C1752930
stimulation	I:C1752930
,	O
increase	O
in	O
fibroblast	B:C0170936
growth	I:C0170936
factor	I:C0170936
receptor	I:C0170936
-	I:C0170936
1c	I:C0170936
activation	B:C1514758
,	O
and	O
prolonged	O
duration	O
of	O
glucose	B:C0860801
lowering	I:C0860801
in	O
ob	B:C0028754
/	I:C0028754
ob	I:C0028754
hyperglycemic	B:C0020456
mice	B:C0025929
.	O

A	O
novel	O
Fibroblast	B:C0079349
growth	I:C0079349
factor	I:C0079349
-	I:C0079349
1	I:C0079349
/	O
fibroblast	B:C0170936
growth	I:C0170936
factor	I:C0170936
receptor	I:C0170936
-	I:C0170936
1c	I:C0170936
dimerization	O
interaction	O
combined	O
with	O
non-phosphorylatable	B:C0243095
intracrine	B:C1154545
signaling	I:C1154545
is	O
hypothesized	O
to	O
be	O
responsible	O
for	O
these	O
observed	O
functional	O
effects	O
.	O

